Is Abnormal Urine Protein/Osmolality Ratio Associated with Abnormal Renal Function in Patients Receiving Tenofovir Disoproxil Fumarate?

• Jasmine R. Marcelin ,

  * E-mail: marcelin.jasmine@mayo.edu (JRM); rizza.stacey@mayo.edu (SAR)

  Affiliation Department of Medicine, Division of Infectious Diseases, Mayo Clinic, Rochester, MN, United States of America

  ⨯
• Melody L. Berg,

  Current address: Department of Pharmacy, Indiana University Health Methodist Hospital, Indianapolis, IN, United States of America

  Affiliation Department of Medicine, Division of Infectious Diseases, Mayo Clinic Rochester, MN, United States of America

  ⨯
• Eugene M. Tan,

  Affiliation Department of Internal Medicine, Mayo Clinic, Rochester, MN, United States of America

  ⨯
• Hatem Amer,

  Affiliation Department of Medicine, Division of Nephrology & Hypertension, Mayo Clinic, Rochester MN, United States of America

  ⨯
• Nathan W. Cummins,

  Affiliation Department of Medicine, Division of Infectious Diseases, Mayo Clinic, Rochester, MN, United States of America

  ⨯
• Stacey A. Rizza

  * E-mail: marcelin.jasmine@mayo.edu (JRM); rizza.stacey@mayo.edu (SAR)

  Affiliation Department of Medicine, Division of Infectious Diseases, Mayo Clinic, Rochester, MN, United States of America

  ⨯